General Updates

Mankindl/JJJ,,. September 28, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/Madam, Sub.: Resignation of Statutory Auditors of Bharat Serums and Vaccines Limited, a Material Wholly Owned Subsidiary of the Company Ref.: Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulations 30 & 51 of the Listing Regulations, read with Para A of Part A of Schedule III thereto and in continuation of our earlier letter dated September 7, 2026, we wish to inform you that S.R. Batliboi & Co. LLP, Chartered Accountants, the Statutory Auditors of Bharat Serums and Vaccines Limited (“BSV”), a material wholly owned subsidiary of Mankind Pharma Limited (“Company”), have tendered their resignation from the office of Statutory Auditors of BSV with effect from September 28, 2026 vide its resignation letter dated September 28, 2026, consequent to the initiation of voluntary liquidation proceedings of BSV under Section 59 of the Insolvency and Bankruptcy Code, 2016 read with the Insolvency and Bankruptcy Board of India (Voluntary Liquidation Process) Regulations, 2017, as amended from time to time. The Statutory Auditors has further confirmed that there is no other material reason for their resignation other than the reason as stated above. The details as required under Regulation 30 of the Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“SEBI Master Circular”) and a copy of the resignation letter, along with the annexure containing the requisite details received from the Statutory Auditors, are enclosed herewith as Annexure-I and Annexure-II, respectively. You are requested to kindly take the same on record. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a MANKIND PHARMA LIMITED Regd. Office: 208, Okhla Ind. Estate, Phase -3, New Delhi-110020 •Ph.: 011-46846700, 47476600 CIN No. L74899DL 1991 PLC044843 •E-mail : contact@mankindpharma.com • www.mankindpharma.com Mankindl/JJJ,,. Annexure-I The details as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular: S. No. Particulars Details Name of the Statutory S.R. Batliboi & Co. LLP, Chartered Accountants Auditors Entity from which Bharat Serums and Vaccines Limited (“BSV”), a material wholly 2. resignation has been owned subsidiary of Mankind Pharma Limited tendered Resignation on account of the initiation of voluntary liquidation Reason for change viz. proceedings of BSV under Section 59 of the Insolvency and appointment, re- Bankruptcy Code, 2016, read with the Insolvency and 3. appointment, Bankruptcy Board of India (Voluntary Liquidation resignation, removal, Process) Regulations, 2017, as communicated by the Statutory death or otherwise Auditors as communicated by the Statutory Auditors. 4. Date of resignation September 28, 2026 (with immediate effect) Brief profile (in case of 5. Not applicable appointment) Disclosure of relationships between 6. the auditor and any Not applicable director/KMP of the material subsidiary MANKIND PHARMA LIMITED Regd. Office: 208, Okhla Ind. Estate, Phase -3, New Delhi-110020 •Ph.: 011-46846700, 47476600 CIN No. L74899DL 1991 PLC044843 •E-mail : contact@mankindpharma.com • www.mankindpharma.com Annexure-II S.R. LLP 67, Institutional Area BATLIBOl&Co. Sector 44, Gurugram • 122 003 Haryana, India Chartered Accountants Tel: +91124 681 6000 Date: September 28, 2026 Board of Directors Bharat Serums & Vaccines Limited 3rd Floor, Liberty tower, Plot No. K-10, Behind Reliable Plaza, Kalwa Industrial Estate, Airoli, Navi Mumbai, Thane, Maharashtra -400708 For the attention of: Mr. Sanjiv Hari Navangul (Managing Director) Sub: Resignation as statutory auditors of the Company Dear Sir, We were appointed as statutory auditors of Bharat Serums & Vaccines Limited ("the Company") in 32nd Annual General Meeting ("AGM") held on September 22, 2025, for a period of 4 years beginning April 1, 2025 till the conclusion of 36th AGM. We refer to the emails dated September 11 and September 15, 2026, from the Liquidator, Mr. Dilipkumar Natvarlal Jagad as per Annexure B, wherein it was stated that the Company's shareholders on September 7, 2026, had resolved to liquidate the Company by way of voluntary liquidation, in accordance with the relevant provisions of the Insolvency and Bankruptcy Code, 2016, read with the Insolvency and Bankruptcy Board of India (Voluntary Liquidation) Regulations, 2017. It was further stated that, under these regulations, a liquidator shall not engage any professional who has served as an auditor of the Company at any time during the five years preceding the liquidation commencement date. Accordingly, we hereby tender our resignation as the Statutory Auditors of the Company and request that you treat this letter as our resignation with immediate effect. We have also discussed this matter with the Management of the Company. Kindly take this on your record and do the needful. As required by Companies Act, 2013, we shall file a statement in Form ADT-3 in the due course and we forward a copy to the Company for record. We have completed the audit of financial statements of the Company for the year ended March 31, 2026, vide audit report dated May 12, 2026, and have not commenced the audit of the Company as at and for the year ended March 31, 2027. We take this opportunity to reiterate our appreciation for the courtesies and co-operations extended to us by your organization. Should you require any assistance in the future, please feel free to contact us. Yours Sincerely, For S.R. Batliboi & Co. LLP Chartered Accountants ICAI Firm registration No: 301003E/E300005 Rajeev Digitally signed by Rajeev Sawhney DN: cn=Rajeev Sawhney, c=IN, Sawhney o=Personal Date: 2026.09.28 12:44:51 +05'30' per Rajeev Sawhney Partner Membership Number: 096333 S.R. Batliboi & Co LLP, a Limited Liability Partnership with LLP Identity No. AAB-4294 Regd. Office: 22, Camac Street, Block 'B', 3rd floor, Kolkata-700 016 S.R. LLP BATLIBOl&Co. Chartered Accountants ANNEXUREA Format of information to be obtained from the statutory auditor upon resignation 1. Name of the listed entity/material subsidiary Bharat Serums & Vaccines Limited (referred to as "the Company") 2. Details of the statutory auditor: S.R. Batliboi & Co. LLP (Firm Registration Number: a. Name 301003E/E300005) b. Address 7th Floor, Plot 67, Sector 44, Gurugram, Haryana 122003 c. Phone number +91 1246816360 d.Email Rajeev.Sawhney@srb.in Details of association with the listed entity /material 3. See Below subsidiary: a. Date on which the statutory auditor was appointed September 22, 2025 Appointed Statutory Auditor for a period of 4 years i.e., from the b. Date on which the term of the statutory auditor was conclusion of the 32nd Annual General Meeting on 22 September scheduled to expire 2025 until the conclusion of the 36th Annual General Meeting. Audit report on the financial statements of the Company for the c. Prior to resignation, the latest audit report/limited review year ended March 31, 2026, dated May 12, 2026. report submitted by the auditor and date of its submission The Company's Shareholders have resolved to voluntarily liquidate the Company with effect from September 7, 2026, pursuant to the relevant provisions of the Insolvency and Bankruptcy Code, 2016, read with the Insolvency and Bankruptcy Board of India (Voluntary Liquidation Process) Regulations, 2017. As per the Insolvency and Bankruptcy Board of India (Voluntary Liquidation Process) Regulations, 2017, a liquidator is prohibited 4. Detailed reasons for resignation from engaging any professional who has served as the auditor of the Company at any time [Showing first 8,000 characters — download PDF for full document]